140
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients

ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon, , , & ORCID Icon show all
Pages 579-587 | Published online: 26 Feb 2020

References

  • Manu P, Kane JM, Correll CU. Sudden deaths in psychiatric patients. J Clin Psychiatry. 2011;72(7):936–941. doi:10.4088/JCP.10m06244gry21672496
  • Takeshima M, Ishikawa H, Shimizu K, Kanbayashi T, Shimizu T. Incidence of venous thromboembolism in psychiatric inpatients: a chart review. Neuropsychiatr Dis Treat. 2018;14:1363–1370. doi:10.2147/NDT29872303
  • Ishida T, Sakurai H, Watanabe K, Iwashita S, Mimura M, Uchida H. Incidence of deep vein thrombosis in catatonic patients: a chart review. Psychiatry Res. 2016;241:61–65. doi:10.1016/j.psychres.2016.04.10527156025
  • Ishida T, Katagiri T, Uchida H, et al. Incidence of deep vein thrombosis in restrained psychiatric patients. Psychosomatics. 2014;55(1):69–75. doi:10.1016/j.psym.2013.04.00123845320
  • Wu CS, Chang CM, Chen CY, et al. Association between antidepressants and venous thromboembolism in Taiwan. J Clin Psychopharmacol. 2013;33(1):31–37. doi:10.1097/JCP.0b013e318277742523277236
  • Lee CW, Liao CH, Lin CL, Liang JA, Sung FC, Kao CH. Depression and risk of venous thromboembolism: a population-based retrospective cohort study. Psychosom Med. 2015;77(5):591–598. doi:10.1097/PSY.000000000000019325984821
  • Adelborg K, Sundbøll J, Videbech P, Grove EL. The risk of thromboembolism in users of antidepressants and antipsychotics. Adv Exp Med Biol. 2017;906:351–361.27638627
  • Branchford BR. Venous thromboembolism risk with antidepressants: driven by disease or drugs? J Am Heart Assoc. 2017;6(5):e006293. doi:10.1161/JAHA.117.00629328515117
  • Parkin L, Balkwill A, Sweetland S, et al. Antidepressants, depression, and venous thromboembolism risk: large prospective study of UK women. J Am Heart Assoc. 2017;6(5):e005316. doi:10.1161/JAHA.116.00531628515116
  • Kunutsor SK, Seidu S, Khunti K. Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence. Ann Med. 2018;50(6):529–537. doi:10.1080/07853890.2018.150070330001640
  • Kuwashiro T, Toyoda K, Oyama N, et al. High plasma D-dimer is a marker of deep vein thrombosis in acute stroke. J Stroke Cerebrovasc Dis. 2012;21(3):205–209. doi:10.1016/j.jstrokecerebrovasdis.2010.06.00920813546
  • Pang H, Wang L, Liu J, et al. The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J. 2018;12(11):2573–2580. doi:10.1111/crj.2018.12.issue-1130207643
  • White C, Noble SIR, Watson M, et al. Prevalence, symptom burden, and natural history of deep vein thrombosis in people with advanced cancer in specialist palliative care units (HIDDen): a prospective longitudinal observational study. Lancet Haematol. 2019;6(2):e79–e88. doi:10.1016/S2352-3026(18)30215-130709436
  • Inoue H, Watanabe H, Okami H, Kimura A, Takeshita K. The rate of venous thromboembolism before and after spine surgery as determined with indirect multidetector CT. JB JS Open Access. 2018;3(3):e0015. doi:10.2106/JBJS.OA.18.0001530533591
  • Chua K, Kong KH, Chan SP. Prevalence and risk factors of asymptomatic lower extremity deep venous thrombosis in Asian neurorehabilitation admissions in Singapore. Arch Phys Med Rehabil. 2008;89(12):2316–2323. doi:10.1016/j.apmr.2008.05.02519061744
  • Kelly J, Rudd A, Lewis RR, Coshall C, Moody A, Hunt BJ. Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke. 2004;35(10):2320–2325. doi:10.1161/01.STR.0000140741.13279.4f15322298
  • Cronin CG, Lohan DG, Keane M, Roche C, Murphy JM. Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. AJR Am J Roentgenol. 2007;189(1):162–170. doi:10.2214/AJR.07.206717579167
  • Ota S, Yamada N, Tsuji A, Ishikura K, Nakamura M, Ito M. Incidence and clinical predictors of deep vein thrombosis in patients hospitalized with heart failure in Japan. Circ J. 2009;73(8):1513–1517. doi:10.1253/circj.CJ-08-099019521019
  • Kawase K, Okazaki S, Toyoda K, et al. Sex difference in the prevalence of deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage. Cerebrovasc Dis. 2009;27(4):313–319. doi:10.1159/00020200619218795
  • Sonoda K, Ikeda S, Mizuta Y, Miyahara Y, Kohno S. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease. J Gastroenterol. 2004;39(10):948–954. doi:10.1007/s00535-004-1426-615549447
  • Ando K, Fujiya M, Nomura Y, et al. The incidence and risk factors of venous thromboembolism in patients with inflammatory bowel disease: a prospective multicenter cohort study. Digestion. 2019;100(4):229–237. doi:10.1159/00049528930554225
  • Ando K, Fujiya M, Nomura Y, et al. The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study. Intest Res. 2018;16(3):416–425. doi:10.5217/ir.2018.16.3.41630090041
  • Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil. 2003;82(5):364–369. doi:10.1097/01.PHM.0000064725.62897.A512704275
  • Schultz DJ, Brasel KJ, Washington L, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J Trauma. 2004;56(4):727–731; discussion 731–733. doi:10.1097/01.TA.0000119687.23542.EC
  • Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331(24):1601–1606. doi:10.1056/NEJM1994121533124017969340
  • Weng MT, Park SH, Matsuoka K, et al. Incidence and risk factor analysis of thromboembolic events in East Asian patients with inflammatory bowel disease, a multinational collaborative study. Inflamm Bowel Dis. 2018;24(8):1791–1800. doi:10.1093/ibd/izy05829726897
  • Münster AM, Rasmussen TB, Falstie-Jensen AM, et al. A changing landscape: temporal trends in incidence and characteristics of patients hospitalized with venous thromboembolism 2006–2015. Thromb Res. 2019;176:46–53. doi:10.1016/j.thromres.2019.02.00930776687
  • Yamaki T, Nozaki M, Sakurai H, et al. Combined use of pretest clinical probability score and latex agglutination D-dimer testing for excluding acute deep vein thrombosis. J Vasc Surg. 2009;50(5):1099–1105. doi:10.1016/j.jvs.2009.06.05919703748
  • Waser G, Kathriner S, Wuillemin WA. Performance of the automated and rapid STA Liatest D-dimer on the STA-R analyzer. Thromb Res. 2005;116(2):165–170. doi:10.1016/j.thromres.2004.12.00315907532
  • Inada T, Inagaki A. Psychotropic dose equivalence in Japan. Psychiatry Clin Neurosci. 2015;69(8):440–447. doi:10.1111/pcn.2015.69.issue-825601291
  • Heit JA, O’Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162(11):1245–1248. doi:10.1001/archinte.162.11.124512038942
  • Sugimura K, Sakuma M, Shirato K. Potential risk factors and incidence of pulmonary thromboembolism in Japan: results from an overview of mailed questionnaires and matched case-control study. Circ J. 2006;70(5):542–547. doi:10.1253/circj.70.54216636487
  • Mahmoodi BK, Cushman M, Anne Næss I, et al. Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies. Circulation. 2017;135(1):7–16. doi:10.1161/CIRCULATIONAHA.116.02450727831499
  • Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 1999;353(9160):1258–1265. doi:10.1016/S0140-6736(98)10265-910217099
  • Baratloo A, Safari S, Rouhipour A, et al. The risk of venous thromboembolism with different generation of oral contraceptives; a systematic review and meta-analysis. Emerg (Tehran). 2014;2(1):1–11.26495334
  • Rovinski D, Ramos RB, Fighera TM, Casanova GK, Spritzer PM. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis. Thromb Res. 2018;168:83–95. doi:10.1016/j.thromres.2018.06.01429936403
  • Sun JM, Kim TS, Lee J, et al. Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapy. Lung Cancer. 2010;69(3):330–336. doi:10.1016/j.lungcan.2009.11.01520007002
  • Maurer M, Heine O, Wolf M, Freyhardt P, Schnapauff D, Hamm B. Safety and tolerability of iobitridol in general and in patients with risk factors: results in more than 160000 patients. Eur J Radiol. 2011;80(2):357–362. doi:10.1016/j.ejrad.2010.03.01820395094
  • Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e419S–e496S. doi:10.1378/chest.11-230122315268
  • Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet. 1985;2(8454):515–518. doi:10.1016/S0140-6736(85)90459-32863541
  • Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of postoperative deep-vein thrombosis. Lancet. 1969;2(7614):230–232. doi:10.1016/S0140-6736(69)90002-64184105
  • Huisman MV, Buller HR, Ten Cate JW, Vreeken J. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study. N Engl J Med. 1986;314(13):823–828. doi:10.1056/NEJM1986032731413053951515
  • Wells PS, Owen C, Doucette S, Fergusson D, Tran H. Does this patient have deep vein thrombosis? JAMA. 2006;295(2):199–207. doi:10.1001/jama.295.2.19916403932
  • Hunt BJ. Plasma D-dimer assays in the diagnosis of venous thromboembolism in cancer patients. J Thromb Haemost. 2006;4(1):50–51. doi:10.1111/jth.2006.4.issue-116409448
  • Fuji T, Fujita S, Tachibana S, Kawai Y. A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty. J Thromb Haemost. 2010;8(11):2458–2468. doi:10.1111/j.1538-7836.2010.04021.x20723033
  • Konstantinides SV, Meyer G. The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2019;40(42):3453–3455. doi:10.1093/eurheartj/ehz72631697840
  • Watanabe H, Madoiwa S, Sekiya H, et al. Predictive blood coagulation markers for early diagnosis of venous thromboembolism after total knee joint replacement. Thromb Res. 2011;128(6):e137–e143. doi:10.1016/j.thromres.2011.07.03021839493
  • Kim JY, Kim KH, Cho JY, et al. D-dimer/troponin ratio in the differential diagnosis of acute pulmonary embolism from non-ST elevation myocardial infarction. Korean J Intern Med. 2019;34(6):1263–1271. doi:10.3904/kjim.2018.15330685960
  • Katz DS, Loud PA, Bruce D, et al. Combined CT venography and pulmonary angiography: a comprehensive review. Radiographics. 2002;22(suppl_1):S3–S19; discussion S20–S24. doi:10.1148/radiographics.22.suppl_1.g02oc17s3